CVS Health's Coram discontinues infusion services for antibiotics, inotropic meds, and more, plans to close or sell 29 regional pharmacies.

The annual enrollment period for Medicare Advantage plans and Medicare Part D prescription drug plans starts Tuesday and runs ...

Analyses of 2025 Medicare Advantage star ratings continue to pour in and not all of it bodes well for the conventional ...

Stock in the healthcare provider Humana came under pressure again on Friday after the U.S. government released quality ...

Aetna®, a CVS Health® company (NYSE: CVS), announced the State of Michigan has recommended the company for a new contract to ...

About 40% of MA plans with prescription drug coverage will earn four or more stars, a dip from 42% this year, according to data released by the CMS.

The prior authorization process for patients with cancer demonstrates fewer days until submission and lower denial rates for Asian patients relative to White patients.

Teva Pharmaceutical Industries will pay $450 to settle the Department of Justice's investigation into allegations of price fixing and misuse of funds for kickbacks. Other pharmaceutical news reports ...

Only 40% of Medicare Advantage health prescription drug plans achieved a four-star rating or higher under the current criteria used by Centers for Medicare and Medicaid Services to grade quality. The ...

Highlights,Aetna, a CVS Health company, reports that 88% of its Medicare Advantage members are enrolled in plans rated 4 ...

Mok CFA covers the Healthcare sector, focusing on stocks such as Centene, CVS Health, and Humana. The word on The Street in general, suggests a Strong Buy analyst consensus rating for UnitedHealth ...

Elevance is a high-quality stock with consistent EPS growth, trading at a significant discount to peers like UnitedHealth.